뒤로
Silo Pharma Inc(SILO) 가격
SILO 주가 차트
SILO 수입
Silo Pharma Inc
$0.37
-0.97%
$0
종가: Jan 16, 16:00:00 GMT-5
$0.38
1.93%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$0.3814
시가
$0.3949
일일 범위
$0.3732 - $0.3949
52주 범위
$0.325 - $2.09
거래량
94.3K
평균 거래량
223.1K
EPS(TTM)
-0.93
배당수익률
--
시가총액
$5.1M
SILO란 무엇인가요?
Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. The company is headquartered in Sarasota, Florida. The company went IPO on 2012-01-05. The Company’s therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes programs, such as for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Its lead product candidate, SPC-15, is designed as a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for treatment of stress-induced psychiatric disorders such as PTSD and anxiety disorders. SPC-14 targets glutamate receptor NDMAR and serotonin 5-HT4 to address cognitive and neuropsychiatric symptoms in Alzheimer’s disease. SPU-16 is a candidate targeting central nervous system (CNS) disorders, with an initial indication for multiple sclerosis.